As filed with the Securities and Exchange Commission on February 4, 2025

Registration No. 333-   

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

METSERA, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   92-0931552

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

3 World Trade Center

175 Greenwich Street

New York, New York 10007

(Address of Principal Executive Offices)

Metsera, Inc. 2023 Equity Incentive Plan

Metsera, Inc. 2025 Incentive Award Plan

Metsera, Inc. 2025 Employee Stock Purchase Plan

(Full Title of the Plans)

Christopher Whitten Bernard

Chief Executive Officer

3 World Trade Center

175 Greenwich Street

New York, New York 10007

(212) 784-6595

(Name, Address and Telephone Number, Including Area Code, of Agent for Service)

 

 

Copies to:

Peter N. Handrinos

B. Shayne Kennedy

J. Ross McAloon

Latham & Watkins LLP

200 Clarendon Street

Boston, Massachusetts 02116

(617) 948-6000

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

Proposed sales to take place as soon after the effective date of the registration statement as awards granted under the above-named plans are granted, exercised and/or distributed.

 

 

 


PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

The documents containing the information specified in Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) of the Securities Act. These documents and the documents incorporated by reference into this registration statement pursuant to Item 3 of Part II of this registration statement, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

In this registration statement, Metsera, Inc. is sometimes referred to as “Registrant,” “we,” “us” or “our.”

Item 3. Incorporation of Documents by Reference.

The Securities and Exchange Commission (“SEC”) allows us to “incorporate by reference” the information we file with them, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this registration statement, and later information filed with the SEC will update and supersede this information. We hereby incorporate by reference into this registration statement the following documents previously filed with the SEC:

 

(a)

The prospectus filed by the Registrant with the SEC pursuant to Rule 424(b) under the Securities Act, dated January 30, 2025 relating to the registration statement on Form S-1, as amended (Registration No. 333-284225); and

 

(b)

The description of the Registrant’s common stock set forth in the Registrant’s registration statement on Form 8-A12B (File No. 001-42489), filed by the Registrant with the SEC under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on January 27, 2025, including any amendments or reports filed for the purpose of updating such description.

In addition, all documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the filing of this registration statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold shall be deemed to be incorporated by reference into this registration statement and to be a part hereof from the date of filing such documents, except as to specific sections of such statements as set forth therein. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement contained herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained in any subsequently filed document which also is incorporated or deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.

Under no circumstances shall any information furnished under Item 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

Item 4. Description of Securities.

See the description of the Registrant’s common stock set forth in the Registrant’s registration statement on Form S-1, as amended (Registration No. 333-284225).

Item 5. Interests of Named Experts and Counsel.

Not applicable.


Item 6. Indemnification of Directors and Officers.

Section 102 of the General Corporation Law of the State of Delaware permits a corporation to eliminate the personal liability of directors of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Our amended and restated certificate of incorporation provides that no director of the Registrant shall be personally liable to it or its stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except to the extent that the General Corporation Law of the State of Delaware prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty.

Section 145 of the General Corporation Law of the State of Delaware provides that a corporation has the power to indemnify a director, officer, employee or agent of the corporation, or a person serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in related capacities against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with an action, suit or proceeding to which he was or is a party or is threatened to be made a party to any threatened, ending or completed action, suit or proceeding by reason of such position, if such person acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.

Our amended and restated certificate of incorporation and our amended and restated bylaws provide that we will indemnify each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding (other than an action by or in the right of us) by reason of the fact that he or she is or was, or has agreed to become, a director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (all such persons being referred to as an “Indemnitee”), or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding and any appeal therefrom, if such Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, and, with respect to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct was unlawful. Our amended and restated certificate of incorporation and our amended and restated bylaws, each as currently in effect, provide that we will indemnify any Indemnitee who was or is a party to an action or suit by or in the right of us to procure a judgment in our favor by reason of the fact that the Indemnitee is or was, or has agreed to become, a director or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys’ fees) and, to the extent permitted by law, amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding, and any appeal therefrom, if the Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests, except that no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to us, unless a court determines that, despite such adjudication but in view of all of the circumstances, he or she is entitled to indemnification of such expenses. Notwithstanding the foregoing, to the extent that any Indemnitee has been successful, on the merits or otherwise, he or she will be indemnified by us against all expenses (including attorneys’ fees) actually and reasonably incurred in connection therewith. Expenses must be advanced to an Indemnitee under certain circumstances.


We have entered into indemnification agreements with each of our directors and officers. These indemnification agreements may require us, among other things, to indemnify our directors and officers for some expenses, including attorneys’ fees, judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of his or her service as one of our directors or officers, or any of our subsidiaries or any other company or enterprise to which the person provides services at our request.

We maintain a general liability insurance policy that covers certain liabilities of directors and officers of our corporation arising out of claims based on acts or omissions in their capacities as directors or officers.

Item 7. Exemption from Registration Claimed.

Not applicable.

Item 8. Exhibits.

 

Exhibit         Incorporated by Reference         Filed

Number

  

Exhibit Description

   Form    File No.    Exhibit    Filing Date         Herewith
  3.1    Amended and Restated Certificate of Incorporation of Metsera, Inc.    8-K    001-42489    3.1    February 3, 2025      
  3.2    Amended and Restated Bylaws of Metsera, Inc.    8-K    001-42489    3.2    February 3, 2025      
  4.1    Specimen stock certificate evidencing the shares of common stock    S-1/A    333-284225    4.1    January 27, 2025      
  5.1    Opinion of Latham & Watkins LLP                   X
 23.1    Consent of Ernst & Young LLP, independent registered public accounting firm                   X
 23.2    Consent of CohnReznick LLP, independent registered public accounting firm                   X
 23.3    Consent of Latham & Watkins LLP (included in Exhibit 5.1)                   X
 24.1    Power of Attorney (see signature page)                   X
 99.1    2023 Equity Incentive Award Plan and form of award agreements thereunder    S-1/A    333-284225    10.1    January 27, 2025    S-1/A   
 99.2    2025 Incentive Award Plan and form of award agreements thereunder    S-1/A    333-284225    10.2    January 27, 2025    S-1/A   
 99.3    2025 Employee Stock Purchase Plan    S-1/A    333-284225    10.3    January 27, 2025    S-1/A   
107.1    Calculation of Filing Fee Table                   X


Item 9. Undertakings.

(a) The undersigned Registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement,

(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii) to reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” table in the effective registration statement; and

(iii) to include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement;

provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if this registration statement is on Form S-8 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement.

(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement, relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.


(h) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.


SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on February 4, 2025.

 

METSERA, INC.
By:   /s/ Christopher Whitten Bernard
  Christopher Whitten Bernard
  President and Chief Executive Officer

SIGNATURES AND POWER OF ATTORNEY

We, the undersigned officers and directors of Metsera, Inc., hereby severally constitute and appoint Christopher Whitten Bernard and Christopher J. Visioli, and each of them singly (with full power to each of them to act alone), our true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities held on the dates indicated.


Signature

  

Title

 

Date

/s/ Christopher Whitten Bernard

  

President and Chief Executive Officer

(principal executive officer)

  February 4, 2025
Christopher Whitten Bernard

/s/ Christopher J. Visioli

  

Chief Financial Officer

(principal financial and accounting officer)

  February 4, 2025
Christopher J. Visioli

/s/ Clive A. Meanwell, M.B., Ch.B., M.D.

   Executive Chairman of the Board   February 4, 2025
Clive A. Meanwell, M.B., Ch.B., M.D.

/s/ Paul L. Berns

   Director   February 4, 2025
Paul L. Berns

/s/ Kristina M. Burow

   Director   February 4, 2025
Kristina M. Burow

/s/ Joshua Pinto, Ph.D.

   Director   February 4, 2025
Joshua Pinto, Ph.D.

Exhibit 5.1

 

  200 Clarendon Street   
  Boston, Massachusetts 02116   
  Tel: +1.617.948.6000 Fax: +1.617.948.6001
 

www.lw.com

 

  
LOGO   FIRM / AFFILIATE OFFICES   
  Austin    Milan   
  Beijing    Munich   
  Boston    New York   
  Brussels    Orange County   
  Century City    Paris   
  Chicago    Riyadh   
  Dubai    San Diego   
  Düsseldorf    San Francisco   
  Frankfurt    Seoul   
  Hamburg    Silicon Valley   
  Hong Kong    Singapore   
  Houston    Tel Aviv   
  London    Tokyo   
  Los Angeles    Washington, D.C.   
  Madrid      

February 4, 2025

Metsera, Inc.

3 World Trade Center

175 Greenwich Street

New York, New York 10007

Re: Registration Statement on Form S-8

To the addressee set forth above:

We have acted as special counsel to Metsera, Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing by the Company on the date hereof with the Securities and Exchange Commission (the “Commission”) of a registration statement (the “Registration Statement”) on Form S-8 under the Securities Act of 1933, as amended (the “Act”), relating to the issuance of up to 20,094,557 shares (the “Shares”) of common stock of the Company, $0.00001 par value per share, which may be issued pursuant to the Company’s 2023 Equity Incentive Plan (the “2023 Plan”), the Company’s 2025 Incentive Award Plan (the “2025 Plan”) and the Company’s 2025 Employee Stock Purchase Plan (the “ESPP”). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related prospectus, other than as expressly stated herein with respect to the issue of the Shares.

As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the “DGCL”), and we express no opinion with respect to any other laws.


February 4, 2025

Page 2

 

LOGO

 

Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, and have been issued by the Company for legal consideration of not less than par value in the circumstances contemplated by the 2023 Plan, 2025 Plan or the ESPP, as applicable, assuming in each case that the individual issuances, grants or awards under the 2023 Plan, 2025 Plan or ESPP, as applicable, are duly authorized by all necessary corporate action and duly issued, granted or awarded and exercised in accordance with the requirements of law and the 2023 Plan, 2025 Plan or the ESPP, as applicable (and the agreements duly adopted thereunder and in accordance therewith), the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and such Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL.

This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

Sincerely,

/s/ Latham & Watkins LLP

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Metsera, Inc. 2023 Equity Incentive Plan, the Metsera, Inc. 2025 Incentive Award Plan, and the Metsera, Inc. 2025 Employee Stock Purchase Plan of Metsera, Inc. of our report dated November 4, 2024 (except Note 14, as to which the date is January 27, 2025), with respect to the consolidated financial statements of Metsera, Inc. included in its Registration Statement (Form S-1 No. 333-284225) and related Prospectus, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Iselin, New Jersey

February 4, 2025

Exhibit 23.2

Consent of Independent Auditors

We consent to the incorporation by reference in this Registration Statement on Form S-8 pertaining to the Metsera, Inc. 2023 Equity Incentive Plan, the Metsera, Inc. 2025 Incentive Award Plan and the Metsera, Inc. 2025 Employee Stock Purchase Plan, of our report dated October 31, 2024, with respect to the consolidated financial statements of Zihipp LTD and Subsidiary as of December 31, 2022 and 2021, and for the years then ended which report is included in the S-1 Registration Statement of Metsera, Inc. (File No. 333-284225) for the registration of shares of its common stock. Our audit report includes an explanatory paragraph relating to Zihipp LTD and Subsidiary’s ability to continue as a going concern.

/s/ CohnReznick LLP

Holmdel, New Jersey

February 4, 2025

Exhibit 107.1

Calculation of Filing Fee Table

Form S-8

(Form Type)

Metsera, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

               
Security Type  

Security

Class

Title

  Fee
Calculation
Rule
  Amount
Registered(1)
  Proposed
Maximum
Offering
Price Per
Unit
 

Maximum
Aggregate
Offering

Price

 

Fee

Rate

  Amount of
Registration
Fee
               
Equity   Common stock issuable upon the exercise of outstanding stock options under the 2023 Equity Incentive Plan (the “2023 Plan”)   457(h)   8,720,086(2)   $4.51(3)   $39,327,588   0.00015310   $6,021.05
               
Equity   Common stock reserved for issuance pursuant to awards under the Registrant’s 2025 Incentive Award Plan (the “2025 Plan”)   457(h)   10,110,641 (4)   $18.00(5)   $181,991,538   0.00015310   $27,862.90
               
Equity   Common stock reserved for issuance pursuant awards under the Registrant’s 2025 Employee Stock Purchase Plan (the “ESPP”)   457(h)   1,263,830 (6)   $18.00(5)   $22,748,940   0.00015310   $3,482.86
       
Total Offering Amounts   $244,068,066     $37,366.81
       
Total Fee Offsets       N/A
       
Net Fee Due           $37,366.81

 

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement (“Registration Statement”) shall also cover any additional shares of common stock that become issuable under the above-named plans, by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without receipt of consideration that results in an increase to the number of outstanding shares of common stock, as applicable.


(2)

Represents 8,720,086 shares of the Registrant’s common stock issuable upon the exercise of outstanding stock options granted under the 2023 Plan, at a weighted-average exercise price of $4.51 per share.

 

(3)

Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457 under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based on $4.51 per share, which is the weighted-average exercise price of the outstanding stock options granted under the 2023 Plan being registered.

 

(4)

Represents 10,110,641 shares of common stock reserved for issuance under the 2025 Plan . The number of shares reserved for issuance or transfer pursuant to awards under the 2025 Plan will be increased by (i) the number of shares represented by awards outstanding under the 2023 Plan, or 2023 Plan Awards, that become available for issuance pursuant to the counting provisions set forth in the 2025 Plan and (ii) an annual increase on each January 1 beginning in 2026 and ending in 2035, equal to the lesser of (A) 5% of the sum of (1) the number of shares of the Registrant’s common stock and (2) the number of shares of the Registrant’s common stock issuable upon the exercise of warrants to purchase shares of the Registrant’s common stock with an exercise price per share of $0.01 or less, in each case, outstanding (on an as converted basis) on the immediately preceding December 31 and (B) such smaller number of shares of stock as determined by the Registrant’s board of directors; provided, however, that no more than 92,000,000 shares of common stock may be issued upon the exercise of incentive stock options.

 

(5)

Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(h) under the Securities Act. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based on the initial public offering price of the common stock of $18.00 per share, as set forth in the Registrant’s Registration Statement on Form S-1 (File No. 333-284225), as amended (the “S-1 Registration Statement”), that was declared effective on January 30, 2025.

 

(6)

Represents 1,263,830 shares of the Registrant’s common stock reserved for issuance under the ESPP. The number of shares of common stock available for issuance under the ESPP will be annually increased on January 1 beginning in 2026 and ending in 2035, equal to the lesser of (i) 1% of the sum of (A) the number of shares of the Registrant’s common stock and (B) the number of shares of the Registrant’s common stock issuable upon the exercise of warrants to purchase shares of the Registrant’s common stock with an exercise price per share of $0.01 or less, in each case, outstanding (on an as converted basis) on the immediately preceding December 31 and (ii) such number of shares of common stock as determined by the Registrant’s board of directors; provided, however, that no more than 17,500,000 shares of common stock may be issued under the ESPP.


Metsera (NASDAQ:MTSR)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse Metsera
Metsera (NASDAQ:MTSR)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse Metsera